View this email in your browser
We're holding another CBTN Community Info Session on Feb. 25! Take an insider's tour of our lab space at Children's Hospital of Philadelphia, meet our lab and data scientists, and learn more about how patient specimen donations power childhood brain tumor research.

Learn More & Register
We need your help!
The Gabriella Miller Kids First Research Act 2.0 (H.R. 6556)

Additional funding is needed to supplement much needed research for childhood cancers and other diseases that strike our Nation’s children. The Kids First Research Act 2.0 would transfer to the Gabriella Miller Kids First Pediatric Research Initiative Fund at the National Institutes of Health existing and future funds derived from registered persons under the Federal Food, Drug and Cosmetic Act for penalties and fines from violations of laws.

The bill has been introduced to Congress by U.S. Representative Jennifer Wexton (VA-10). Legislation of this kind benefits everyone involved in CBTN and can provide crucial funding to advance our shared goals.  

You can lend your support for the Kids First Research Act 2.0 by
adding your name to our general letter of support. PLEASE SHARE THE LINK! The more names of support that can be added, the more we can show broad public support for the effort. 
Requesting CBTN Biospecimens and Data

The CBTN accepts requests for CBTN cell lines and data projects year-round, with resources available to researchers anywhere on earth.  Proposals for scientific biospecimen projects from investigators will also be accepted any time of year!

For more information and instructions on submitting requests for CBTN biosamples, cell lines, and data, visit us online at:
NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome Published in JCO Precision Oncology - Jan. 14, 2021

“Our findings demonstrate that NTRK fusions are far more frequently seen in pediatric tumors than in adult tumors and involve a broader panel of fusion partners and wider range of pediatric tumors than previously recognized...”
-Dr. Marilyn M. Li, MD

Defining the Global Impact of Somatic Structural Variation on the Transcriptome of Human Pediatric Brain Cancers

Read our Q&A with Dr. Creighton about his CBTN project and recent research findings, published this month in Nature Communications.

Subscribe to the CBTN Newsletter
Copyright © 2021 Children's Hospital of Philadelphia/Center for Data-Driven Discovery in Biomedicine, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp